Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks.
Authors: Diamant, Michaela1 m.diamant@vumc.nl, Van Gaal, Luc2, Stranks, Stephen3, Guerci, Bruno4, MacConell, Leigh5, Haber, Harry6, Scism-Bacon, Jamie7, Trautmann, Michael8
Source: Diabetes Care. Apr2012, Vol. 35 Issue 4, p683-689. 7p. 1 Diagram, 2 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:01495992
DOI:10.2337/dc11-1233